FDA Adverse Event Injury Summary report: N

GYNECARE PROLIFT ANTERIOR PELVIC FLOOR REPAIR SYSTEM

MDR report key: 3241414 · Received July 22, 2013

Report

Report Number
2210968-2013-14012
Event Type
Injury
Date Received
July 22, 2013
Report Date
October 25, 2016
Manufacturer
ETHICON INC.
Product Code
OTP
PMA / PMN Number
K013718
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY.

Additional Manufacturer Narrative · 1

(B)(4). IT WAS REPORTED BY AN ATTORNEY THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE ON (B)(6) 2007 AND A MESH WAS IMPLANTED DUE TO ANTERIOR VAGINAL VAULT PROLAPSE, APICAL VAULT PROLAPSE, AND SUI. IT WAS REPORTED THAT FOLLOWING INSERTION THE PATIENT EXPERIENCED PAIN, EROSION, EXTRUSION, INFECTION, BLEEDING, AND DYSPAREUNIA. IT WAS REPORTED THE PATIENT UNDERWENT CYSTOSCOPY, RESECTION OF VAGINAL MESH IN THE ANTERIOR VAGINAL WALL, RESECTION OF ERODED MIDURETHRAL SLING MESH AT RIGHT LATERAL SIDE ON (B)(6) 2015 DUE TO VAGINAL BLEEDING WITH MESH EROSION. NO ADDITIONAL INFORMATION WAS PROVIDED.

Additional Manufacturer Narrative · 1

IN ADDITION, A DEVICE HISTORY REVIEW HAS BEEN INSERTED INTO THE FILE. THIS REVIEW INDICATES THAT THERE WAS NO QUALITY CONCERNS ASSOCIATED WITH THE MANUFACTURING PROCESS.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE ON (B)(6) 2007 AND MESH WAS IMPLANTED. THE PATIENT EXPERIENCED PAIN, EROSION OF INTERNAL TISSUES, AND HAS UNDERGONE ADDITIONAL SURGERIES AND REVISIONARY PROCEDURES. NO ADDITIONAL INFORMATION IS PROVIDED AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
341516 GYNECARE PROLIFT ANTERIOR PELVIC FLOOR REPAIR SYSTEM MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC OTP ETHICON INC. UNK 3038625

Patients

Seq Age Sex Outcome Treatment
1 52 YR Required Intervention